The Centers for Disease Control finalizes advisory panel recommendations for Gardasil

April 2, 2007

The Centers for Disease Control & Prevention has adopted the unanimous recommendations of its Advisory Committee on Immunization Practices for the use of Gardasil.

The Centers for Disease Control & Prevention has adopted the unanimous recommendations of its Advisory Committee on Immunization Practices for the use of Gardasil (quadrivalent human papillomavirus [types 6,11, 16, 18] recombinant vaccine) in girls and women ages 11 through 26. Gardasil is indicated to help prevent cervical cancer, precancerous and low-grade cervical lesions, vulvar and vaginal precancers, and genital warts caused by human papillomavirus (HPV) types 6, 11, 16, and 18. The vaccination guidelines, published on-line in the most recent issue of the CDC's Morbidity and Mortality Weekly Report, finalize the provisional recommendation issued by ACIP in June 2006.

To see more Hot off the Press news articles, click here.

To go to the Drug Topics homepage, click here.